Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors*
暂无分享,去创建一个
Gianluigi Zona | A. Bajetto | T. Florio | F. Barbieri | Giorgio Corte | Antonio Daga | G. Zona | M. Capra | R. Spaziante | A. Pattarozzi | R. Favoni | A. Daga | Alessandra Pattarozzi | Tullio Florio | Fabrizio Griffero | Daniela Marubbi | Maria Cristina Capra | Alice Melotti | Monica Gatti | Adriana Bajetto | Carola Porcile | Federica Barbieri | Roberto E Favoni | Michele Lo Casto | Renato Spaziante | C. Porcile | Monica Gatti | Fabrizio Griffero | G. Corte | M. Lo Casto | A. Melotti | Daniela Marubbi
[1] L. Muzio,et al. Effects of Emx2 inactivation on the gene expression profile of neural precursors , 2006, The European journal of neuroscience.
[2] Yoshimasa Uehara,et al. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway. , 2002, Molecular cancer therapeutics.
[3] S. Anderson,et al. Epidermal Growth Factor Protects Epithelial Cells against Fas-induced Apoptosis , 1999, The Journal of Biological Chemistry.
[4] Alexander Brawanski,et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.
[5] M. Robello,et al. Chemokine Stromal Cell-Derived Factor 1α Induces Proliferation and Growth Hormone Release in GH4C1 Rat Pituitary Adenoma Cell Line through Multiple Intracellular Signals , 2006, Molecular Pharmacology.
[6] D. Durden,et al. Mechanisms of Disease: the PI3K–Akt–PTEN signaling node—an intercept point for the control of angiogenesis in brain tumors , 2007, Nature Clinical Practice Neurology.
[7] H. Mehdorn,et al. Expression of stem cell markers in human astrocytomas of different WHO grades , 2007, Journal of Neuro-Oncology.
[8] A. Bajetto,et al. EGFR inhibitors and glioblastoma tumor initiating cells 1 DIFFERENT RESPONSE OF HUMAN GLIOMA TUMOR-INITIATING CELLS TO EGFR KINASE INHIBITORS , 2009 .
[9] M. Goodell,et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[11] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[12] G. Stassi,et al. Cancer stem cells – old concepts, new insights , 2008, Cell Death and Differentiation.
[13] H. Nakauchi,et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.
[14] S. Rafii,et al. AC133/CD133/Prominin-1. , 2005, The international journal of biochemistry & cell biology.
[15] H. Poulsen,et al. The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[17] E. Parati,et al. Epidermal and Fibroblast Growth Factors Behave as Mitogenic Regulators for a Single Multipotent Stem Cell-Like Population from the Subventricular Region of the Adult Mouse Forebrain , 1999, The Journal of Neuroscience.
[18] Guido Reifenberger,et al. Pten signaling in gliomas. , 2002, Neuro-oncology.
[19] D. Louis,et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. , 2001, Genes & development.
[20] T. Palmer,et al. Fibroblast Growth Factor-2 Activates a Latent Neurogenic Program in Neural Stem Cells from Diverse Regions of the Adult CNS , 1999, The Journal of Neuroscience.
[21] M. Kuwano,et al. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. , 2004, Molecular cancer therapeutics.
[22] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[23] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[24] P. Stork,et al. G Protein Activation of a Hormone-Stimulated Phosphatase in Human Tumor Cells , 1992, Science.
[25] J. Woodburn,et al. The epidermal growth factor receptor and its inhibition in cancer therapy. , 1999, Pharmacology & therapeutics.
[26] M. Clarke,et al. Cancer stem cells: models and concepts. , 2007, Annual review of medicine.
[27] J. Hainfellner,et al. Malignant glioma: Neuropathology and Neurobiology , 2006, Wiener Medizinische Wochenschrift.
[28] Ugo Orfanelli,et al. Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.
[29] G. Lapertosa,et al. Expression of Somatostatin Receptor mRNA in Human Meningiomas and their Implication in in vitro Antiproliferative Activity , 2004, Journal of Neuro-Oncology.
[30] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[31] Arturo Alvarez-Buylla,et al. EGF Converts Transit-Amplifying Neurogenic Precursors in the Adult Brain into Multipotent Stem Cells , 2002, Neuron.
[32] P. Lichter,et al. Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients , 2008, Clinical Cancer Research.
[33] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[34] U. Rodeck,et al. Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage. , 2003, Cancer research.
[35] Michael Dean,et al. Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.
[36] T. Florio. Somatostatin/somatostatin receptor signalling: Phosphotyrosine phosphatases , 2008, Molecular and Cellular Endocrinology.
[37] K. Black,et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.
[38] M. Diehn,et al. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. , 2006, Journal of the National Cancer Institute.
[39] A. Dowlati,et al. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy. , 2004, Molecular cancer therapeutics.
[40] S. Weiss,et al. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[41] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[42] M. Noble,et al. Cancer stem cells. , 2006, The New England journal of medicine.
[43] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[44] Daniel H. Geschwind,et al. Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] P. Dirks,et al. Cancer stem cells in nervous system tumors , 2004, Oncogene.
[46] Koji Yoshimoto,et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. , 2005, The New England journal of medicine.
[47] A. Ratto,et al. 17β-Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment , 2008, Molecular Pharmacology.
[48] M. Culler,et al. Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. , 2008, Endocrine-related cancer.
[49] T. Iwama,et al. Epidermal Growth Factor Plays a Crucial Role in Mitogenic Regulation of Human Brain Tumor Stem Cells* , 2008, Journal of Biological Chemistry.
[50] W. Kamphorst,et al. Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma? , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[51] A. Fusco,et al. The Expression of the Phosphotyrosine Phosphatase DEP-1/PTPη Dictates the Responsivity of Glioma Cells to Somatostatin Inhibition of Cell Proliferation* , 2004, Journal of Biological Chemistry.
[52] Michael F Clarke,et al. Recent advances in cancer stem cells. , 2008, Current opinion in genetics & development.
[53] Fang Tan,et al. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.